Last $0.15 USD
Change Today -0.015 / -8.83%
Volume 189.1K
INNV On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

innovus pharmaceuticals inc (INNV) Snapshot

Open
$0.14
Previous Close
$0.17
Day High
$0.16
Day Low
$0.14
52 Week High
03/13/14 - $0.93
52 Week Low
07/8/14 - $0.11
Market Cap
4.1M
Average Volume 10 Days
62.7K
EPS TTM
$-0.19
Shares Outstanding
26.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for INNOVUS PHARMACEUTICALS INC (INNV)

Related News

No related news articles were found.

innovus pharmaceuticals inc (INNV) Related Businessweek News

No Related Businessweek News Found

innovus pharmaceuticals inc (INNV) Details

Innovus Pharmaceuticals, Inc., a pharmaceutical company, is engaged in the commercialization, licensing, and development of non-prescription pharmaceutical and consumer health products in the United States and internationally. Its male and female sexual health and vitality products include EjectDelay, an over-the-counter monograph-compliant benzocaine-based topical gel for treating premature ejaculation; CIRCUMserum, a non-medicated cream to alleviate reduced penile sensitivity; Zestra, a non-medicated patented natural product to increase desire and arousal, and reduce pain from sexual intercourse in women; and Zestra Glide, a clinically tested water-based longer lasting lubricant. The company also provides pain management products comprising Apeaz, an OTC monograph-compliant topical cream for the relief of arthritis pain; and Xyralid, an OTC monograph compliant lidocaine-based spray in development for the relief of hemorrhoids. It markets its products directly or through commercial partners to primary care physicians, urologists, gynecologists, and therapists; and directly to consumers through on-line channels, retailers, and wholesalers. Innovus Pharmaceuticals, Inc. is based in San Diego, California.

2 Employees
Last Reported Date: 03/28/14

innovus pharmaceuticals inc (INNV) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

innovus pharmaceuticals inc (INNV) Key Developments

Innovus Pharmaceuticals Unveils Zestra and Zestra Glide for FSI/AD in Morocco; Sothema Labsan Receives Exclusive License From Innovus Pharmaceuticals, Inc. to Market and Sell Zestra and Zestra Glide for Female Sexual Desire Disorder

Innovus Pharmaceuticals reported the official launch of Zestra and Zestra Glide for treating Female Sexual Desire Disorder (FSI/AD) in pharmacies in Morocco. The launch was initiated by the company's partner Sothema Laboratories (Sothema Labs). The launch press conference took place at the Hyatt Regency Hotel in Casablanca and was attended by Dr. Bassam Damaj, the president and CEO of the Innovus Pharma along with the executives of Sothema Labs. Sothema Labs launched the products with an initial order of approximately 200,000 doses. Zestra is promoted by Sothema Laboratories' large sales force and is dispensed with a physician prescription. Zestra is a patented blend of natural oils clinically-proven in double-blind placebo-controlled clinical trials in 276 women to increase in a statistical significant manner the arousal, desire and sexual satisfaction in FSI/AD women. It is the first NHP product to receive approval for FSI/AD in Canada. In addition, Sothema Labsan received the exclusive license to market and sell Zestra and Zestra Glide for Female Sexual Desire Disorder (FSI/AD). The product is now marketed in the North African countries, the Gulf Countries Middle East (excluding Lebanon and Israel) and West Africa. Under the agreement, Innovus will receive an upfront payment and is eligible to receive up to approximately USD 171.25 million upon and subject to the achievement of sales milestones based on cumulative supplied units of the licensed products in the Territory plus a pre-negotiated transfer price per unit.

Innovus Pharmaceuticals, Inc. Presents at 17th Annual BIO CEO & Investor Conference, Feb-09-2015 08:00 AM

Innovus Pharmaceuticals, Inc. Presents at 17th Annual BIO CEO & Investor Conference, Feb-09-2015 08:00 AM. Venue: The Waldorf Astoria, New York, New York, United States. Speakers: Bassam B. Damaj, Chief Executive Officer, President and Director.

Innovus Pharmaceuticals, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015

Innovus Pharmaceuticals, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 . Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INNV:US $0.15 USD -0.015

INNV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for INNV.
View Industry Companies
 

Industry Analysis

INNV

Industry Average

Valuation INNV Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.2x
Price/Book 218.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INNOVUS PHARMACEUTICALS INC, please visit www.innovuspharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.